BioSpace News Archive

Mission Bio, a leader in single-cell multi-omic solutions for precision medicine, today launched the Tapestri® Genome Editing Solution.

A new agreement is poised to accelerate antibiotic access for tens of thousands of patients in regions with the highest rates of antimicrobial resistance.

Bausch Health Companies Inc. is pleased to announce that following its approval by Health Canada the new treatment PrUCERIS® aerosol foam is now available across Canada to treat mild to moderate distal ulcerative colitis in adults.

FibroBiologics, a clinical-stage biotechnology company focused on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, announced the dedication of its cutting-edge laboratory facility as the Newlin-Linscomb Lab for Cell Therapeutics, within the University of Houston Innovation Center.

Alto Neuroscience Inc. today announced Amit Etkin, M.D., Ph.D., founder and chief executive officer, will present at the following investor conferences.

IQVIA™ has been named a Leader in the IDC Marketscape Worldwide Life Science R&D Pharmacovigilance Solutions 2022 Vendor Assessment.

OpenFold, a non-profit artificial intelligence (AI) research consortium whose goal is to develop free and open-source software tools for biology and drug discovery

Molecular Targeting Technologies, Inc., a clinical-stage company accelerating the development and global access of life-changing radiopharmaceuticals, announced the appointment of Dr. Jerry Huang, M.D., Ph.D. as the Senior Vice President of Clinical Development.

United Therapeutics Corporation, a public benefit corporation, announced the release of its 2023 Corporate Responsibility and Public Benefit Report covering its 2022 progress toward its public benefit goals and objectives and summarizing its efforts to advance the interests of its patients and other stakeholders.

Caris Life Sciences®, announced that Loyola University Chicago’s Stritch School of Medicine has joined the Caris Precision Oncology Alliance™.